| Trial ID: | L0003 |
| Source ID: | NCT03425708
|
| Associated Drug: |
20mg Febuxostat
|
| Title: |
Effect of Hyperuricaemia on Chronic Renal Disease
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hyperuricemia|Chronic Renal Disease
|
| Interventions: |
DRUG: 20mg Febuxostat|DRUG: 40mg Febuxostat
|
| Outcome Measures: |
Primary: serum uric acid, intravenous blood sampling, up to 6 months | Secondary: serum creatinine, intravenous blood sampling, up to 6 months
|
| Sponsor/Collaborators: |
Sponsor: The Affiliated Hospital of Xuzhou Medical University | Collaborators: The First People's Hospital of Xuzhou
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
400
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2017-01-01
|
| Completion Date: |
2018-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2018-02-07
|
| Locations: |
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221000, China
|
| URL: |
https://clinicaltrials.gov/show/NCT03425708
|
